TY  - RPRT
TI  - Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.
AU  - H Yoshizawa
AU  - A E Chang
AU  - S Shu
PY  - 1991
UR  - https://pubmed.ncbi.nlm.nih.gov/1830072/
ID  - 1830072
ER  -